Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A Hutchinson

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1979
Selection bias in evaluation therapy for end-stage renal disease: suggestions for a solutionT A Hutchinson
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 24, 2001
Bayesian assessment of adverse drug reactionsT A Hutchinson
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 22, 1999
The price and challenges of extraordinary success: treating end-stage renal failure in the next millenniumT A Hutchinson
Clinical Nephrology|August 1, 1984
The outcome of hyponatremia in a general hospital populationD Baran, T A Hutchinson
Journal of Clinical Epidemiology|January 1, 1989
Assessing methods for causality assessment of suspected adverse drug reactionsT A Hutchinson, D A Lane
Journal of Chronic Diseases|January 1, 1986
Standardized methods of causality assessment for suspected adverse drug reactionsT A Hutchinson, D A Lane
Drug Information Journal|December 12, 1983
The Yale algorithm. Special workshop--clinicalM S Kramer, T A Hutchinson
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 7, 1998
Death: a rewarding experience?T A Hutchinson, J F Seely
Journal of Chronic Diseases|January 1, 1987
The notion of "acceptable risk": the role of utility in drug managementD A Lane, T A Hutchinson
Journal of Vascular Surgery|March 1, 1986
Long-term prognosis of surgical treatment of renovascular hypertension: a fifteen-year experienceJ E Morin, T A Hutchinson, R Lisbona
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1979
Selection bias in evaluation therapy for end-stage renal disease: suggestions for a solutionT A Hutchinson
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 24, 2001
Bayesian assessment of adverse drug reactionsT A Hutchinson
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 22, 1999
The price and challenges of extraordinary success: treating end-stage renal failure in the next millenniumT A Hutchinson
Clinical Nephrology|August 1, 1984
The outcome of hyponatremia in a general hospital populationD Baran, T A Hutchinson
Journal of Clinical Epidemiology|January 1, 1989
Assessing methods for causality assessment of suspected adverse drug reactionsT A Hutchinson, D A Lane
Journal of Chronic Diseases|January 1, 1986
Standardized methods of causality assessment for suspected adverse drug reactionsT A Hutchinson, D A Lane
Drug Information Journal|December 12, 1983
The Yale algorithm. Special workshop--clinicalM S Kramer, T A Hutchinson
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 7, 1998
Death: a rewarding experience?T A Hutchinson, J F Seely
Journal of Chronic Diseases|January 1, 1987
The notion of "acceptable risk": the role of utility in drug managementD A Lane, T A Hutchinson
Journal of Vascular Surgery|March 1, 1986
Long-term prognosis of surgical treatment of renovascular hypertension: a fifteen-year experienceJ E Morin, T A Hutchinson, R Lisbona
Pageof 5